Ultrasound
Less than 1 min.Read

Novuson Reports Direct Therapeutic Ultrasound Improving Surgical Safety and Precision

Novuson announces the recent launch of their Regulation Crowdfunding raise. Join us in improving surgical safety and precision.

Novuson is focused on finishing validation studies for the regulatory clearance of our first-in-class Ultrastat 3mm MiniLS advanced energy sealer/divider. Energy based surgical instruments are used in most surgical procedures. They improve surgical efficiency.

We intend to revolutionize surgical safety and precision,” said Founder and CEO, Dr. Stuart Mitchell. “We at Novuson believe the Ultrastat 3mm MiniLS vessel sealer/divider will disrupt the surgical market, improving patient safety with DTU precision.”

With the help of StartEngine, we are excited to announce the commencement of our equity crowdfunding campaign. Equity crowdfunding allows companies like Novuson to raise capital from the public.  Investors will hold partial ownership in Novuson and will have the opportunity to profit if and when Novuson does well.

More information here.

SourceNovuson

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

0
Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330